www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Activists hope to thwart IPO bid

Updated: 2012-02-11 08:10

By Jin Zhu and Tan Zongyang (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

Drug firm that makes traditional medicine with bear bile would use funds to keep more animals

FUZHOU - A pharmaceutical company in Fujian province that makes medicines from bear bile has again been targeted by animal rights activists as it makes a second attempt to become publicly listed.

Guizhentang Pharmaceuticals, founded in 2000, extracts bile from captive bears to make traditional Chinese medicines. The company keeps 470 bears and hopes to increase the number to 1,200, according to its website.

Activists hope to thwart IPO bid

Bai Yipeng, founder of China SOS Help, a non-government organization whose activities include advocating for animal rights, said on Wednesday he had formed an alliance with others to buy shares of the drug company in order to stop it from going public.

Guizhentang could raise up to 120 million yuan ($19 million) with the initial public offering, Bai said, more than twice the estimated value of its first IPO attempt - 50 million yuan - last year, according to China Securities Journal.

On Feb 1, the China Securities Regulatory Commission released a list of 220 companies awaiting approval by the Growth Enterprise Board to trade on the Shenzhen Stock Exchange. Guizhentang was one of them.

"Our social morality has come to a crossroads. Whether the company goes public or not is a matter of life and death for the suffering bears," Bai said on his micro blog on Wednesday. He added that the fundraising would help the company expand its farm where the bears are kept and increase the number of bears in captivity.

Bai said he had sent the tender offer to three big investors in the drug company, and it might be received in one or two days. He hoped those shareholders would make the "right" decision by accepting the offer within 10 days.

"If we succeed in buying enough shares as a large shareholder with a right to veto business decisions, we will strategically make the drug company diversified in its production and abolish bile extraction from bears," he said.

The company said it hasn't got the offering proposal from any individuals or activist groups yet.

"So far we haven't received documentation from Mr Bai about the proposal to buy shares," said an employee surnamed Xu in the company's administrative office.

Xu said he couldn't say whether opponents will stop the company's IPO plan or not, and that he would need permission from the company's senior executives, who can't immediately be reached for comment.

Guizhentang's attempt to go public last year triggered furious protests from animal rights groups and netizens who accused it of cruelty in the captive breeding of bears and method of bile extraction. The company argued that the method was legal and has replaced the traditional method, which was to first kill the bears.

On its website, Guizhentang says it can collect bile in five to eight minutes without causing the bears pain.

The company is expected to use the funds raised by the IPO to expand the size of its farm and the number of its bears to 1,200.

Guizhentang is not the only drug company extracting bear bile for medicines. Another such pharmaceutical company, Kaibao Pharma Co in Shanghai, was listed in January 2010.

"The company's move got the attention of animal activists several months later. There were not so many people concerned about the practice of extracting bear bile at the time," said Zhang Xiaohai, director of external affairs of Animals Asia Foundation's China Office, which is based in Hong Kong.

"But now, we (the foundation) are inspired, because more people are concerned not only about the cruelty, but also related industries," he said.

Bear bile has been used in traditional medicine in China and other Asian countries because it is thought to have benefits, such as detoxification, cleansing the liver and improving vision.

In the 1980s, captive breeding replaced the original method of killing wild black bears to get the bile.

By 2006, China had 68 registered bear farms where about 7,000 black bears were kept for bile extraction, according to the State Forestry Administration.

The number of bear farms increased to 98 in 2011.

Bear farms can now be found in 11 provinces, such as Jilin, Heilongjiang, Sichuan, and Yunnan, according to the foundation.

Medical professionals say bears are subjected to crude surgery that leaves permanent wounds in the abdominal wall and their gall bladders, causing serious diseases and even killing many of the animals.

As parts of its efforts to end bear farming in China, the foundation has rescued 277 black bears from farms in the past 10 years.

As of January, 111 of the rescued bears had later died, and 38 percent of those from liver cancer, according to the foundation.

"The bile extracted from the sick black bears is very likely to carry a cancer cell, which could trigger health risks when ingested by humans," said Wang Shengxian, head of the pathology department at Chengdu Military General Hospital.

"Years of research showed that we can produce drugs with substitutes that have the same properties as the drugs with bear bile," said Jiang Qi, former vice-president of Shenyang Pharmaceutical University.

So far, government authorities have not approved the substitute drugs for sale on the market, Jiang said.

主站蜘蛛池模板: 国产免费高清在线精品一区 | 青青草国产一区二区三区 | 色久综合网 | 韩国免又爽又刺激激情视频 | 国产日产欧产精品精品推荐在线 | 午夜欧美 | 国产日产欧美a级毛片 | 久久精品久久精品国产大片 | 久久黄色一级视频 | 黄录像欧美片在线观看 | 亚洲欧美二区三区久本道 | 亚洲夜| 久久91精品国产91 | 97一级毛片全部免费播放 | 最近日本免费观看视频 | 亚洲男人的天堂在线观看 | 国产成人综合久久亚洲精品 | 国产边打电话边做对白刺激 | 亚洲高清国产品国语在线观看 | se94se欧美| 色狠狠色综合吹潮 | 亚洲精品国产一区二区三区四区 | 二区久久国产乱子伦免费精品 | 亚州国产 | 91精品成人免费国产片 | 亚洲天堂视频在线 | 亚洲天堂.com | 自拍偷拍视频在线观看 | 人人草97| 岛国片欧美一级毛片 | 欧美a级完整在线观看 | 欧美精品在线视频 | 成人在线免费观看 | 久久国产精品久久久久久 | 日韩精品一区二区三区四区 | 欧美高清正版在线 | 久久精品免费观看 | 亚洲成a人v大片在线观看 | 免费一级网站 | 亚洲人成在线精品 | 九热视频在线观看 |